Rapid review of multisystem inflammatory syndrome in paediatrics: What we know one year later
Background: Multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (COVID-19) is an emerging condition that was first identified in paediatrics at the onset of the COVID-19 pandemic. The condition is also known as pediatric inflammatory multisystem syndrome te...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN FR |
Publicado: |
Public Health Agency of Canada
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/72364b68b8f34018b3505fe3db5547d5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:72364b68b8f34018b3505fe3db5547d5 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:72364b68b8f34018b3505fe3db5547d52021-11-18T19:53:13ZRapid review of multisystem inflammatory syndrome in paediatrics: What we know one year later10.14745/ccdr.v47i11a041481-8531https://doaj.org/article/72364b68b8f34018b3505fe3db5547d52021-11-01T00:00:00Zhttps://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-11-november-2021/rapid-review-multisystem-inflammatory-syndrome-paediatrics-canada.htmlhttps://doaj.org/toc/1481-8531Background: Multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (COVID-19) is an emerging condition that was first identified in paediatrics at the onset of the COVID-19 pandemic. The condition is also known as pediatric inflammatory multisystem syndrome temporally associated with severe acute respiratory syndrome coronavirus 2 (PIMS-TS or PIMS), and multiple definitions have been established for this condition that share overlapping features with Kawasaki Disease and toxic shock syndrome. Methods: A review was conducted to identify literature describing the epidemiology of MIS-C, published up until March 9, 2021. A database established at the Public Health Agency of Canada with COVID-19 literature was searched for articles referencing MIS-C, PIMS or Kawasaki Disease in relation to COVID-19. Results: A total of 195 out of 988 articles were included in the review. The median age of MIS-C patients was between seven and 10 years of age, although children of all ages (and adults) can be affected. Multisystem inflammatory syndrome in children disproportionately affected males (58% patients), and Black and Hispanic children seem to be at an elevated risk for developing MIS-C. Roughly 62% of MIS-C patients required admission to an intensive care unit, with one in five patients requiring mechanical ventilation. Between 0% and 2% of MIS-C patients died, depending on the population and available interventions. Conclusion: Multisystem inflammatory syndrome in children can affect children of all ages. A significant proportion of patients required intensive care unit and mechanical ventilation and 0%–2% of cases resulted in fatalities. More evidence is needed on the role of race, ethnicity and comorbidities in the development of MIS-C.Megan StrihaRojiemiahd EdjocNatalie BreseeNicole AtchessiLisa WaddellTerri-Lyn BennettEmily ThompsonMaryem El Jaouhari Samuel Bonti-AnkomahPublic Health Agency of Canadaarticlemultisystem inflammatory syndrome in childrenpediatric multisystem inflammatory syndromecovid-19mis-cpimspims-tsInfectious and parasitic diseasesRC109-216ENFRCanada Communicable Disease Report , Vol 47, Iss 11, Pp 466-472 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN FR |
topic |
multisystem inflammatory syndrome in children pediatric multisystem inflammatory syndrome covid-19 mis-c pims pims-ts Infectious and parasitic diseases RC109-216 |
spellingShingle |
multisystem inflammatory syndrome in children pediatric multisystem inflammatory syndrome covid-19 mis-c pims pims-ts Infectious and parasitic diseases RC109-216 Megan Striha Rojiemiahd Edjoc Natalie Bresee Nicole Atchessi Lisa Waddell Terri-Lyn Bennett Emily Thompson Maryem El Jaouhari Samuel Bonti-Ankomah Rapid review of multisystem inflammatory syndrome in paediatrics: What we know one year later |
description |
Background: Multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (COVID-19) is an emerging condition that was first identified in paediatrics at the onset of the COVID-19 pandemic. The condition is also known as pediatric inflammatory multisystem syndrome temporally associated with severe acute respiratory syndrome coronavirus 2 (PIMS-TS or PIMS), and multiple definitions have been established for this condition that share overlapping features with Kawasaki Disease and toxic shock syndrome.
Methods: A review was conducted to identify literature describing the epidemiology of MIS-C, published up until March 9, 2021. A database established at the Public Health Agency of Canada with COVID-19 literature was searched for articles referencing MIS-C, PIMS or Kawasaki Disease in relation to COVID-19.
Results: A total of 195 out of 988 articles were included in the review. The median age of MIS-C patients was between seven and 10 years of age, although children of all ages (and adults) can be affected. Multisystem inflammatory syndrome in children disproportionately affected males (58% patients), and Black and Hispanic children seem to be at an elevated risk for developing MIS-C. Roughly 62% of MIS-C patients required admission to an intensive care unit, with one in five patients requiring mechanical ventilation. Between 0% and 2% of MIS-C patients died, depending on the population and available interventions.
Conclusion: Multisystem inflammatory syndrome in children can affect children of all ages. A significant proportion of patients required intensive care unit and mechanical ventilation and 0%–2% of cases resulted in fatalities. More evidence is needed on the role of race, ethnicity and comorbidities in the development of MIS-C. |
format |
article |
author |
Megan Striha Rojiemiahd Edjoc Natalie Bresee Nicole Atchessi Lisa Waddell Terri-Lyn Bennett Emily Thompson Maryem El Jaouhari Samuel Bonti-Ankomah |
author_facet |
Megan Striha Rojiemiahd Edjoc Natalie Bresee Nicole Atchessi Lisa Waddell Terri-Lyn Bennett Emily Thompson Maryem El Jaouhari Samuel Bonti-Ankomah |
author_sort |
Megan Striha |
title |
Rapid review of multisystem inflammatory syndrome in paediatrics: What we know one year later |
title_short |
Rapid review of multisystem inflammatory syndrome in paediatrics: What we know one year later |
title_full |
Rapid review of multisystem inflammatory syndrome in paediatrics: What we know one year later |
title_fullStr |
Rapid review of multisystem inflammatory syndrome in paediatrics: What we know one year later |
title_full_unstemmed |
Rapid review of multisystem inflammatory syndrome in paediatrics: What we know one year later |
title_sort |
rapid review of multisystem inflammatory syndrome in paediatrics: what we know one year later |
publisher |
Public Health Agency of Canada |
publishDate |
2021 |
url |
https://doaj.org/article/72364b68b8f34018b3505fe3db5547d5 |
work_keys_str_mv |
AT meganstriha rapidreviewofmultisysteminflammatorysyndromeinpaediatricswhatweknowoneyearlater AT rojiemiahdedjoc rapidreviewofmultisysteminflammatorysyndromeinpaediatricswhatweknowoneyearlater AT nataliebresee rapidreviewofmultisysteminflammatorysyndromeinpaediatricswhatweknowoneyearlater AT nicoleatchessi rapidreviewofmultisysteminflammatorysyndromeinpaediatricswhatweknowoneyearlater AT lisawaddell rapidreviewofmultisysteminflammatorysyndromeinpaediatricswhatweknowoneyearlater AT terrilynbennett rapidreviewofmultisysteminflammatorysyndromeinpaediatricswhatweknowoneyearlater AT emilythompson rapidreviewofmultisysteminflammatorysyndromeinpaediatricswhatweknowoneyearlater AT maryemeljaouhari rapidreviewofmultisysteminflammatorysyndromeinpaediatricswhatweknowoneyearlater AT samuelbontiankomah rapidreviewofmultisysteminflammatorysyndromeinpaediatricswhatweknowoneyearlater |
_version_ |
1718420734265524224 |